Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study Meeting Abstract
| Authors: | Jabbour, E.; Tholouli, E.; Sandhu, K. S.; Shaughnessy, P.; Barba, P.; Guerreiro, M.; Yallop, D.; Logan, A.; Abedi, M.; Lao-Sirieix, P.; Zhang, Y.; Brugger, W.; Pule, M. A.; Shah, B. D.; Bishop, M. R.; Park, J. H.; DeAngelo, D. J.; Peggs, K.; Roddie, C. |
| Abstract Title: | Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401574 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.6504 |
| Notes: | Meeting Abstract: 6504 -- Source: Wos |
